Navidea biopharmaceuticals, inc. (NAVB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-11,192

-10,948

-11,336

-12,084

-11,805

-16,114

-17,012

-14,579

-17,373

74,945

75,122

76,452

74,958

-14,309

-12,937

-20,948

-23,958

-27,563

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-36,182

-33,974

-29,509

-29,157

-29,530

-599

3,046

5,612

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

83

103

115

118

119

120

133

146

183

232

329

390

433

496

509

530

562

562

558

551

526

487

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

Loss on disposal and abandonment of patents and equipment

-

-

-

-

-

-

-

-

-

-807

-806

-957

-236

-136

-136

-4

-27

-33

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-18

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

Loss on disposal and abandonment of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Change in inventory reserve

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

77

147

212

353

492

630

766

815

844

901

958

884

765

0

0

0

-

0

0

0

-

-

-

-

Compounded interest on long term debt

-

-

-

-

-

-

-

-

163

265

405

567

879

1,561

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock compensation expense

209

232

223

217

230

306

335

354

385

394

286

272

84

277

763

1,110

1,602

2,368

2,518

1,593

2,047

1,634

1,746

3,046

2,858

2,908

2,775

2,592

2,628

2,304

2,241

3,441

3,005

3,592

0

0

0

Equity in loss of R-NAV, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-786

-523

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Equity in loss of R-NAV, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

153

1,255

416

1,873

2,858

2,844

2,106

-1,216

-614

-2,935

-1,768

-7

-1,342

155

188

280

-112

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

153

0

0

0

-

-

-

-

-

-

-

-

-1,342

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-265

-182

-952

0

0

0

Loss on extinguishment of debt

-

-

-

-

-

-5,291

-7,153

-7,153

-7,153

-4,201

0

0

0

-

-

-

-

-

-

-

-

-2,610

-2,610

-2,610

-3,982

-1,372

0

0

0

-

-

-

-

-

-

-

-

Value of stock issued to directors

-

-

-

-

-

-

-

-

-

10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Value of stock issued in payment of employee bonuses

0

-

-

-

-

616

316

316

166

369

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Value of stock issued to 401(k) plan for employer matching contributions

-

-

-

-

-

35

35

35

89

53

0

0

0

-

-

-

-

117

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issued warrants in connection with Asset Sale

-

-

-

-

-

-

-

-

-

3,337

3,337

3,337

3,337

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Value of restricted stock issued to directors

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Value of stock issued to employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Value of stock issued in payment of services

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

15

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issued stock to 401(k) plan for employer matching contributions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Issuance of common stock to 401(k) Plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts and other receivables

-781

68

58

-167

-12,945

-12,926

-14,401

-16,070

-3,668

11,145

11,013

12,941

13,841

-1,882

1,489

1,613

1,511

2,808

459

1,342

624

-334

0

0

0

-

44

76

-9

-6

-61

214

442

219

0

0

0

Inventory

-

-

-

-

-

-

-

-

-

-1,470

-804

-726

-854

861

-24

-374

350

-135

-104

-78

-882

-761

-383

576

1,246

1,934

1,401

411

-51

-524

-203

-56

93

53

0

0

0

Prepaid expenses, right-of-use lease assets, and other assets

-983

-696

-926

-398

-537

-805

797

760

818

934

-671

-264

72

-187

313

297

-437

-263

-221

-9

535

476

327

-770

-284

-84

314

592

374

385

4

458

252

40

0

0

0

Accounts payable

601

687

223

219

152

-430

-359

-916

-2,335

-6,017

-3,668

-3,428

469

5,441

3,681

3,776

995

290

-1,078

-316

-520

-944

670

-1,214

560

1,003

-266

1,908

1,073

736

676

-297

235

-538

0

0

0

Accrued, lease and other liabilities

184

-195

-227

752

571

548

251

-2,412

-2,608

-6,248

-4,269

-457

1,627

5,351

3,525

1,955

-952

-282

281

-890

895

-1,250

1,087

2,767

2,525

3,176

831

256

-461

125

-673

-1,327

-560

487

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-15

-2,315

-15

-681

-945

1,104

-1,378

-958

-945

1,237

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

109

0

0

0

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,646

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-8,140

-9,354

-8,748

-8,292

4,369

4,275

4,440

5,381

-10,835

59,083

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-31,775

-27,133

-24,727

-23,923

-26,319

-24,965

-20,811

-16,010

0

0

0

Cash flows from investing activities:
Maturities of available-for-sale securities

-

400

800

800

1,200

1,400

1,200

1,200

800

400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Payments for purchases) proceeds from disposal of equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent and trademark costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

-

-

-

-

1,114

1,588

1,675

1,869

1,239

808

960

877

663

706

479

268

183

0

0

0

Proceeds from sales of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Patent and trademark costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27

52

72

75

77

76

50

58

52

30

22

10

8

5

50

47

52

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-44

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

479

770

801

583

780

953

1,178

1,171

-1,433

-1,833

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-839

-982

-887

-671

-556

26,863

27,078

27,158

0

0

0

Cash flows from financing activities:
Proceeds from issuance of common stock

7,886

7,086

6,046

9,046

3,050

3,000

3,018

18

18

72

67

67

67

13

0

5

65

65

65

60

33

87

87

30,088

35,157

41,303

43,269

13,483

8,747

2,724

823

1,436

2,186

7,198

0

0

0

Proceeds from issuance of MT Preferred Stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of common stock issuance costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

Payment of tax withholdings related to stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

130

75

75

70

659

659

659

662

8

0

0

0

-

-

-

-

Payment of preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

100

100

100

100

0

0

0

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54,500

54,500

54,500

3,000

30,000

30,000

30,000

55,000

29,000

0

0

0

-

-

-

0

-

-

-

-

Payment of debt-related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,763

1,829

2,928

1,177

1,177

1,111

0

153

0

0

0

-

-

-

-

Payment of debt-related costs

-

-

-

-

-

-

-

-

-

1,314

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on notes payable

371

359

393

393

394

395

396

360

373

59,753

59,717

59,673

59,730

231

0

0

0

-

-

-

-

25,000

24,999

25,080

30,246

5,982

0

0

0

-

-

-

35

62

0

0

0

Restricted cash held for payment against debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,001

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments under capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

2

2

2

2

2

2

2

2

4

5

7

8

7

6

5

5

5

6

8

0

0

0

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,290

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

6,792

6,155

5,081

8,080

-4,497

-4,548

-4,531

-7,495

-354

-60,995

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

66,035

36,801

13,556

5,069

6,323

7,510

5,933

11,075

0

0

0

Net decrease in cash and cash equivalents

-869

-2,428

-2,865

371

653

680

1,087

-943

-12,623

-3,745

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,626

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net (decrease) increase in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-21,122

-

-34,243

-8,166

16,160

23,820

33,421

8,685

-12,058

-19,525

0

0

0

-

-

-

-